1. Home
  2. MDGL vs TX Comparison

MDGL vs TX Comparison

Compare MDGL & TX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$600.02

Market Cap

12.5B

Sector

Health Care

ML Signal

HOLD

Logo Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

TX

Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

HOLD

Current Price

$38.59

Market Cap

7.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDGL
TX
Founded
2011
1961
Country
United States
Luxembourg
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
12.5B
7.3B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
MDGL
TX
Price
$600.02
$38.59
Analyst Decision
Strong Buy
Buy
Analyst Count
14
6
Target Price
$580.77
$36.42
AVG Volume (30 Days)
277.7K
165.8K
Earning Date
11-04-2025
10-28-2025
Dividend Yield
N/A
7.02%
EPS Growth
N/A
635.85
EPS
N/A
2.97
Revenue
$740,640,000.00
$15,710,564,000.00
Revenue This Year
$435.63
N/A
Revenue Next Year
$52.56
$7.28
P/E Ratio
N/A
$12.92
Revenue Growth
864.21
N/A
52 Week Low
$265.00
$24.00
52 Week High
$615.00
$39.00

Technical Indicators

Market Signals
Indicator
MDGL
TX
Relative Strength Index (RSI) 64.74 58.04
Support Level $535.33 $37.86
Resistance Level $615.00 $38.89
Average True Range (ATR) 19.64 0.93
MACD 0.57 -0.02
Stochastic Oscillator 81.93 81.43

Price Performance

Historical Comparison
MDGL
TX

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel and Mining. In its Steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The vast majority of its revenue comes from the Steel segment and geographically from Mexico.

Share on Social Networks: